Activin A neutralization through systemic intravenous injection of the antibody significantly increased the number of ECs and the mRNA levels of the EC marker CD31 and antiapoptotic Bcl2 genes compared to injection of control IgG isotype antibodies in melanoma-bearing mice (Fig. 8a,b and Extended Data Fig. 9b). The gene discussed is BCL2; the disease is melanoma.